The rising prevalence of chronic diseases such as cancer, diabetes, and gastrointestinal disorders is a key driver behind this market expansion. Patients with these conditions often require parenteral ...

Episode four of The Leaders’ Room’s season two features outgoing SAP Ireland managing director, Liam Ryan. This series is created in partnership with IDA Ireland. Season two of The Leaders’ Room ...

On the first day of the week, the Brent benchmark rose 2.7% to $75.1/barrel in light of the cartel's announcement to delay ...

The Securities and Exchange Commission (American stock market regulator) reportedly concluded its investigation into Grifols ...

EST Brookfield still pursuing Grifols (GRFS) deal, Bloomberg reports Published first on TheFly – the ultimate source for ...

Brookfield Asset Management (BAM) is awaiting information from Grifols (GRFS) about related-party transactions as it seeks to complete its due ...

Grifols (NASDAQ:GRFS) rose 4% after a report that Brookfield Asset Management (BAM) is still evaluating a takeover of the ...

Brookfield Asset Management is awaiting information from Grifols SA about related-party transactions as it seeks to complete ...

Younger patients in the U.S. can now benefit from Grifols Fibrin Sealant (FS) and its positive effect on surgical outcomes, including a fast time to hemostasisGrifols surgical bleeding management ...

The approved of Vistaseal has been expanded to include use in pediatric patients as an adjunct to hemostasis for mild to moderate bleeding.

Berenberg Bank upgraded shares of Grifols (NASDAQ:GRFS – Free Report) to a strong-buy rating in a report released on Tuesday, Zacks.com reports. Grifols Price Performance Shares of NASDAQ GRFS opened ...

As global markets react to rising U.S. Treasury yields and a tempered outlook for Federal Reserve rate cuts, small-cap stocks have felt the pressure more acutely than their large-cap counterparts. In ...